Novel Linkers for Antibody-Drug Conjugates |
United States |
Immunology |
|
|
Precision Targeting of Castration Resistant Prostate Cancer with a Novel Ferrous Iron-Dependent Therapeutic Delivery and Tumor Imaging Strategy |
United States |
Cancer/Oncology, Immunology |
|
|
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Identification of Novel Therapeutics Molecules against Old and New World Cutaneous Leishmaniasis |
United States |
Drug and Diagnostics Development |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Discovery of Novel Antimalarial Leads Targeting Translational Repression in Plasmodium parasites |
United States |
Malaria |
|
|
Chemical Methods for Ferrous Iron Targeted Drug Delivery |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
United States |
Malaria |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
United States |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease |
Brazil |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Identification of Anti-HIV Lead Compounds Targeting |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS |
|
|
Evolution and Inhibition of Serine Beta-Lactamase Activity |
United States |
Opportunistic Infection, Drug and Diagnostics Development |
|
|